A phase 1 study of lenvatinib, multiple receptor tyrosine kinase inhibitor, in Japanese patients with advanced solid tumors
Crossref DOI link: https://doi.org/10.1007/s00280-015-2899-0
Published Online: 2015-11-03
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakamichi, Shinji
Nokihara, Hiroshi
Yamamoto, Noboru
Yamada, Yasuhide
Honda, Kazunori
Tamura, Yosuke
Wakui, Hiroshi
Sasaki, Tatsuya
Yusa, Wataru
Fujino, Katsuki
Tamura, Tomohide
License valid from 2015-11-03